Table: Mochida Pharm - 9-MTH group results

Mochida Pharmaceutical

05/02/2024 05:00

Feb 5 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             78.22               81.39           102.00    
                 (-3.9 pct)          (-4.0 pct)       (-1.2 pct)  
  Operating          5.79               10.36             5.50    
                 (-44.1 pct)         (-20.6 pct)      (-35.4 pct) 
  Recurring          6.06               10.64             5.70    
                 (-43.0 pct)         (-20.9 pct)      (-37.3 pct) 
  Net                4.44                8.08             4.40    
                 (-45.0 pct)         (-20.6 pct)      (-33.8 pct) 
  EPS            123.48 yen          216.47 yen       123.85 yen  
  Ann Div                             80.00 yen        80.00 yen  
  -Q2 div         40.00 yen           40.00 yen                   
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T